Cardiff Oncology Inc (CRDF)
3.20
+0.02
(+0.63%)
USD |
NASDAQ |
May 31, 16:00
3.21
+0.01
(+0.31%)
After-Hours: 20:00
Cardiff Oncology Cash from Investing (TTM): 33.50M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 33.50M |
December 31, 2023 | 36.20M |
September 30, 2023 | 29.65M |
June 30, 2023 | 31.00M |
March 31, 2023 | 27.12M |
December 31, 2022 | 38.15M |
September 30, 2022 | 22.34M |
June 30, 2022 | 25.22M |
March 31, 2022 | -1.392M |
December 31, 2021 | -131.45M |
September 30, 2021 | -122.71M |
June 30, 2021 | -130.91M |
March 31, 2021 | -111.91M |
December 31, 2020 | -0.211M |
September 30, 2020 | -0.154M |
June 30, 2020 | -0.0623M |
March 31, 2020 | -0.0623M |
December 31, 2019 | -0.0676M |
September 30, 2019 | -0.0676M |
June 30, 2019 | 0.0542M |
March 31, 2019 | 0.0227M |
December 31, 2018 | 0.0228M |
September 30, 2018 | 0.0595M |
June 30, 2018 | -0.1154M |
March 31, 2018 | 18.77M |
Date | Value |
---|---|
December 31, 2017 | 23.96M |
September 30, 2017 | 24.34M |
June 30, 2017 | 27.83M |
March 31, 2017 | -19.30M |
December 31, 2016 | -24.83M |
September 30, 2016 | -26.23M |
June 30, 2016 | -30.17M |
March 31, 2016 | -2.338M |
December 31, 2015 | -2.234M |
September 30, 2015 | -1.321M |
June 30, 2015 | -0.8541M |
March 31, 2015 | -0.4284M |
December 31, 2014 | -0.2998M |
September 30, 2014 | -0.3138M |
June 30, 2014 | -0.4228M |
March 31, 2014 | -0.6744M |
December 31, 2013 | -0.6493M |
September 30, 2013 | -0.629M |
June 30, 2013 | -0.4892M |
March 31, 2013 | -0.2654M |
December 31, 2012 | -0.2701M |
September 30, 2012 | -0.2122M |
June 30, 2012 | -0.141M |
March 31, 2012 | -0.098M |
December 31, 2011 | -0.0015M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-131.45M
Minimum
Dec 2021
38.15M
Maximum
Dec 2022
-12.79M
Average
-0.0623M
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
BioVie Inc | 12.73M |
Biolase Inc | -0.345M |
Tenon Medical Inc | 1.354M |
Adial Pharmaceuticals Inc | -- |
AIM ImmunoTech Inc | -0.912M |